Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLifting weights while taking Wegovy is not only safe for most people — it's actively encouraged by clinicians. Semaglutide reduces appetite significantly, and without deliberate resistance training, some of the weight you lose may come from muscle rather than fat. That's why Wegovy's licensed use specifically pairs the medicine with increased physical activity, not just a lower-calorie diet. These are prescription-only medicines, and a prescriber will talk through the right approach for your health and fitness level before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you eat less, your body draws energy from both fat stores and muscle tissue. This isn't unique to Wegovy, it happens with any sustained calorie deficit. The difference on semaglutide is that the appetite reduction can be dramatic, so the deficit can be larger than people expect, and protein intake often drops alongside total food intake.
In the STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks. A proportion of that was lean mass, as is typical in any significant weight-loss intervention. The question isn't whether this can happen (it can) but how much of it is preventable. The honest answer: quite a lot, with the right approach.
Resistance training sends a clear signal to the body to hold onto muscle even when calories are low. It doesn't need to mean heavy barbells or a gym membership. Two or three sessions a week of bodyweight exercises, resistance bands, or free weights, done consistently, is enough to make a meaningful difference for most people. If you're new to this, starting light and building gradually is exactly the right approach.
This is the question our prescribers hear regularly, and it matters more than most people realise. Wegovy blunts hunger so effectively that some patients find themselves eating far less than they need to support both weight loss and muscle retention. The target to aim for (discussed with your prescriber or a dietitian) is adequate protein spread across the day. Protein requirements for people doing resistance training are higher than general population recommendations, particularly when in a calorie deficit.
Practical pointers: protein-rich foods tend to be more satiating per calorie than carbohydrates, which means they fit naturally with the reduced appetite that Wegovy produces. Eggs, fish, chicken, Greek yoghurt, legumes and cottage cheese are all worth building meals around. Staying hydrated matters too, nausea is a common early side effect of semaglutide, and dehydration can make it worse and leave you feeling too flat to train. For detailed guidance on how doses are structured during treatment, including the titration period when side effects tend to be most noticeable, that page covers the schedule clearly.
The NHS's guidance on weight-management injections is clear that diet and physical activity are central to treatment, not afterthoughts, the medicine works best when both are in place.
In the first few weeks of treatment, or after a dose increase, some people find their energy for training dips. Nausea, fatigue and a smaller appetite can all play a role. This is temporary for most. Once the body adjusts to the current dose, most patients find they can train as normal, often better, as body weight decreases and joints feel less loaded.
A few practical things worth knowing. First, training on a very empty stomach can make nausea worse on this medicine, so a small protein-containing snack before a session can help. Second, the medicine slows gastric emptying, which means food stays in the stomach longer than usual; this is useful for appetite control but means you may feel fuller during exercise if you've eaten recently. Give yourself a bit more time between a meal and a workout than you might have before. If you want to understand how different Wegovy strengths relate to weight-loss progress, there's a dedicated page on that, and if you've reached the maintenance dose, the 2.4mg Wegovy click chart is a handy reference for getting your injection settings right.
If fatigue is persistent rather than temporary, that's worth raising with your prescriber. It can sometimes point to inadequate calorie or protein intake rather than anything related to the medicine itself.
It doesn't reduce Wegovy's effect on appetite or fat loss. What it does do is change the composition of the weight you lose (more fat, less muscle) and that matters for how you look, feel and move as the weight comes off. It also supports metabolic rate; muscle is metabolically active tissue, and losing it can make long-term weight maintenance harder.
There's also the psychological side. People who exercise regularly during weight-loss treatment tend to report feeling stronger and more in control of the process, rather than just watching the scales. That's worth something. If you're thinking about starting treatment and want to know how to approach it from the beginning, starting a free consultation is the natural first step, a prescriber can talk through your fitness goals alongside your health picture. For broader reading on Wegovy, including its licensed uses and eligibility, the Wegovy overview page is a good place to start. And if you're curious about where the highest strength fits into the titration journey, that's covered in full separately.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.